Product
CAS
Specification
Documents
Trimethyl Phloroglucinol
621-23-8
In-house
Technical Package
Moxifloxacin HCL Intermediates
151213-42-2、151213-40-0
In-house
Technical Package
SNAC
203787-91-1
In-house
Technical Package
Tegoprazan Intermediates
844648-19-7 844648-22-2 942195-91-7
In-house
Technical Package
Tegoprazan Intermediates
2648486-30-8 2648486-31-9 2648486-32-0
In-house
Technical Package
Tegoprazan Intermediates
403-21-4 942195-55-3 619-14-7 1369878-15-8
In-house
Technical Package
Ubrogepant Intermediates
137628-17-2 1227585-65-0 1455358-05-0
In-house
Technical Package
Ubrogepant Intermediates
1455358-09-4 1455358-11-8 1455358-12-9
In-house
Technical Package
Ubrogepant Intermediates
1455358-14-1 1455358-16-3 1375541-21-1
In-house
Technical Package
Ubrogepant Intermediates
1455358-19-6 56-54-2 1456803-43-2
In-house
Technical Package
Ubrogepant Intermediates
1455358-06-1 3430-17-9 1235305-63-1 1260403-56-2
In-house
Technical Package
Selumetinib Intermediates
197520-71-1 284030-57-5 284030-58-6 918321-18-3
EP
Technical Package
Selumetinib Intermediates
918321-27-4 918321-20-7 606144-02-9 606093-58-7
In-house
Technical Package
Selumetinib Intermediates
606144-42-7 1415564-48-5 1000340-06-6
In-house
Technical Package
Dabigatran Intermediates
41263-74-5 429659-01-8 212322-56-0 211915-84-3
In-house
Technical Package
Dabigatran Intermediates
1188263-64-0 211915-06-9 872728-81-9
In-house
Technical Package
Dabigatran Intermediates
103041-38-9 42288-26-6 6092-54-2
In-house
Technical Package
Isavuconazonium Intermediates
2942-59-8 32399-12-5 1180002-01-0 338990-31-1
EP
Technical Package
Isavuconazonium Intermediates
20099-89-2 586-89-0 67014-02-2 1443-80-7
In-house
Technical Package
Isavuconazonium Intermediates
241479-67-4 241479-74-3 368421-58-3
In-house
Technical Package
Any Products under parent listted here solely for the permitted purpose,usage and behaviors in accordance with applicable patent Law and regulations in relevant countries.No commercial,sale or other behaviors prohibited by law will be taken or accepted before the expiration of the parent in relevant country.The customers shall evaluate the patent status of the products and be responsible for patent infringement.
